The rapid economic development, modernization and adoption of a Western lifestyle in China have been accompanied by the emergence of chronic disease epidemics. As a result, cardiovascular disease and cancer have now replaced infectious diseases as the leading causes of death in most cities in China. The burden of chronic disease is expected to continue increasing as the Chinese population ages. The Vanderbilt Institute for Medicine and Public Health and the Vanderbilt Institute for Global Health are partnering with the Shanghai Institutes of Preventive Medicine (SIPM), Fudan University, and the Shanghai Cancer Institute (SCI) to establish the Vanderbilt-Shanghai Chronic Disease Research Training Program (VU-Shanghai CDRTP).
The specific aims of the CDRTP are: (1) to train a cadre of experts to conduct multi-disciplinary chronic disease research and build training capacity in China;(2). to train a new generation of scientists and future leaders in chronic diseases research in China;(3) to build research capacity in China and establish long-term collaborative relationships with Vanderbilt chronic disease researchers;(4) to ensure and document the long-term success of the training programs in China that are being facilitated and upgraded through this award;(5) to build national and international leadership in chronic disease prevention and control through existing and newly established networks. The training program includes scholar training (3 months at Vanderbilt), graduate training (1-2 years of didactic course work at Fudan University, a 3-month research practicum at SIPM or SCI, and 1 year of thesis research at Vanderbilt), two five-day, in-country workshops, and an international conference. The training will focus on advanced epidemiological and biostatistical methodology, design and execution of multidisciplinary research projects, and building expertise on cancer, cardiovascular disease and diabetes research, as well as grant writing skills. The VU-Shanghai CDRTP, building upon the strength of existing research and training programs and long-standing collaborations among the participating institutes, will have a significant and long-term impact on chronic disease research and prevention in China.

Public Health Relevance

Chronic disease is emerging as the leading health burden in China. Vanderbilt will partner with public health leaders in Shanghai to train cadre of experts and next generation of researchers in chronic disease research, to build the research capacity and local training facilities. This program will have significant impact on chronic disease research and prevention in China, and possibly extend to other developing countries.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Training Grants (D43)
Project #
5D43TW008313-05
Application #
8525478
Study Section
Special Emphasis Panel (ZRG1-BDA-L (50))
Program Officer
Michels, Kathleen M
Project Start
2009-08-08
Project End
2014-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
5
Fiscal Year
2013
Total Cost
$209,729
Indirect Cost
$15,535
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Huang, Yan-Hong; Wu, Qi-Jun; Li, Li-Li et al. (2016) Different extent in decline of infant mortality by region and cause in Shenyang, China. Sci Rep 6:24527
Li, Da; Yang, Da-Lei; An, Jing et al. (2016) Effect of assisted hatching on pregnancy outcomes: a systematic review and meta-analysis of randomized controlled trials. Sci Rep 6:31228
Li, Na; Chen, Yan-Ling; Li, Jing et al. (2016) Decreasing prevalence and time trend of gastroschisis in 14 cities of Liaoning Province: 2006-2015. Sci Rep 6:33333
Gong, Ting-Ting; Li, Da; Wu, Qi-Jun et al. (2016) Cholesterol consumption and risk of endometrial cancer: a systematic review and dose-response meta-analysis of observational studies. Oncotarget 7:16996-7008
Wu, Qi-Jun; Li, Li-Li; Li, Jing et al. (2016) Time trends of neonatal mortality by causes of death in Shenyang, 1997-2014. Oncotarget 7:16610-8
Sun, Yaqiong; Ye, Chuanzhong; Guo, Xingyi et al. (2016) Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1. Carcinogenesis 37:163-8
Huang, Zhezhou; Zheng, Ying; Wen, Wanqing et al. (2016) Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years. Eur J Cancer 63:1-10
Sun, Yaqiong; Wu, Jie; Cai, Hui et al. (2016) A prospective study of autoantibodies to Ezrin and pancreatic cancer risk. Cancer Causes Control 27:831-5
Gao, Jing; Yang, Gong; Wen, Wanqing et al. (2016) Impact of known risk factors on endometrial cancer burden in Chinese women. Eur J Cancer Prev 25:329-34
Gong, Ting-Ting; Wu, Qi-Jun; Chen, Yan-Ling et al. (2016) Evaluating the time trends in prevalence of exomphalos in 14 cities of Liaoning province, 2006 to 2015. Sci Rep 6:32901

Showing the most recent 10 out of 37 publications